PRESS RELEASE TiGenix to participate and present at key investor and business development meetings Leuven BELGIUM September 28 2017 0700h CET TiGenix NV Euronext Brussels and NASDAQ TIG an advanced biopharmaceutical company focused on exploitin...
↧